Literature DB >> 18354169

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.

Sarah R Jacobs1, Catherine E Herman, Nancie J Maciver, Jessica A Wofford, Heather L Wieman, Jeremy J Hammen, Jeffrey C Rathmell.   

Abstract

T cell activation potently stimulates cellular metabolism to support the elevated energetic and biosynthetic demands of growth, proliferation, and effector function. We show that glucose uptake is limiting in T cell activation and that CD28 costimulation is required to allow maximal glucose uptake following TCR stimulation by up-regulating expression and promoting the cell surface trafficking of the glucose transporter Glut1. Regulation of T cell glucose uptake and Glut1 was critical, as low glucose prevented appropriate T cell responses. Additionally, transgenic expression of Glut1 augmented T cell activation, and led to accumulation of readily activated memory-phenotype T cells with signs of autoimmunity in aged mice. To further examine the regulation of glucose uptake, we analyzed CD28 activation of Akt, which appeared necessary for maximal glucose uptake of stimulated cells and which we have shown can promote Glut1 cell surface trafficking. Consistent with a role for Akt in Glut1 trafficking, transgenic expression of constitutively active myristoylated Akt increased glucose uptake of resting T cells, but did not alter Glut1 protein levels. Therefore, CD28 appeared to promote Akt-independent up-regulation of Glut1 and Akt-dependent Glut1 cell surface trafficking. In support of this model, coexpression of Glut1 and myristoylated Akt transgenes resulted in a synergistic increase in glucose uptake and accumulation of activated T cells in vivo that were largely independent of CD28. Induction of Glut1 protein and Akt regulation of Glut1 trafficking are therefore separable functions of CD28 costimulation that cooperate to promote glucose metabolism for T cell activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354169      PMCID: PMC2593791          DOI: 10.4049/jimmunol.180.7.4476

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction.

Authors:  S Krauss; M D Brand; F Buttgereit
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

4.  Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells.

Authors:  Candace M Cham; Thomas F Gajewski
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter.

Authors:  T Asano; K Takata; H Katagiri; H Ishihara; K Inukai; M Anai; H Hirano; Y Yazaki; Y Oka
Journal:  FEBS Lett       Date:  1993-06-21       Impact factor: 4.124

6.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

7.  Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1.

Authors:  A Barthel; S T Okino; J Liao; K Nakatani; J Li; J P Whitlock; R A Roth
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells.

Authors:  F Michel; L Grimaud; L Tuosto; O Acuto
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

9.  Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production.

Authors:  E F Greiner; M Guppy; K Brand
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line.

Authors:  O Kan; S A Baldwin; A D Whetton
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  344 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

Review 3.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 4.  Signals controlling rest and reactivation of T helper memory lymphocytes in bone marrow.

Authors:  Koji Tokoyoda; Andreas Radbruch
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

5.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 6.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 7.  Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response.

Authors:  Kelsey Voss; Sasha E Larsen; Andrew L Snow
Journal:  Cancer Lett       Date:  2017-09-01       Impact factor: 8.679

Review 8.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

9.  Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells.

Authors:  Samik Basu; Britany Hubbard; Ethan M Shevach
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

10.  Effector T cells require fatty acid metabolism during murine graft-versus-host disease.

Authors:  Craig A Byersdorfer; Victor Tkachev; Anthony W Opipari; Stefanie Goodell; Jacob Swanson; Stacy Sandquist; Gary D Glick; James L M Ferrara
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.